Jubilant Life Sciences posts Q4 & FY 2015 results
Revenue was posted at Rs 763 crore and consolidated revenue was at Rs 5,826 crore
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Jubilant Life sciences
Pharmexcil organises series of initiatives during CPhI Japan
Brand India Pharma was strongly represented by Indian pharma companies at various platforms
Jubilant Life Sciences conferred with Golden Peacock National Quality Award
Recognised under the ‘Chemicals and Pharmaceutical category’ for consistent efforts in quality enhancement
Jubilant Life Sciences appoints Gurpartap Singh Sachdeva as CEO
Jubilant Life Sciences has appointed Gurpartap Singh Sachdeva has been appointed as the Chief Executive Officer, Jubilant Pharma,…
Jubilant Life Sciences, Lupin and Aurobindo Pharma receives US FDA approval for Valsartan tabs
Jubilant Life Sciences, Lupin and Aurobindo Pharma have received final approval from the US Food and Drug Administration (US FDA)…
Jubilant Life Sciences receives US FDA nod for Mycophenolate and MofetilRizatriptan tablets
Mycophenolate Mofetil is an immunosuppressant to help prevent organ rejection in transplants and Rizatriptan is used for the…